The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Chissov V.I.

Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena Rosmedtekhnologiĭ, Moskva

Solodky V.A.

Russian Research Center for Radiology of Healthcare Ministry of the Russian Federation, Moscow, Russia

Pak D.D.

FGBU "Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena" Minzdravsotsrazvitiia Rossii

Rozhkova N.I.

FGBU "Rossiĭskiĭ nauchnyĭ tsentr rentgenoradiologii" Minzdrava Rossii, Moskva

Ermoshchenkova M.V.

FGBU "Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena" Minzdravsotsrazvitiia Rossii

Kireeva M.N.

FGBU "Rossiĭskiĭ nauchnyĭ tsentr rentgenoradiologii" Minzdrava Rossii, Moskva

Breast cancer screening: history and prospects

Authors:

Chissov V.I., Solodky V.A., Pak D.D., Rozhkova N.I., Ermoshchenkova M.V., Kireeva M.N.

More about the authors

Journal: P.A. Herzen Journal of Oncology. 2013;2(2): 46‑51

Views: 2878

Downloaded: 123

Download PDF (RU)
Contact the author
Table of contents

To cite this article:

Chissov VI, Solodky VA, Pak DD, Rozhkova NI, Ermoshchenkova MV, Kireeva MN. Breast cancer screening: history and prospects. P.A. Herzen Journal of Oncology. 2013;2(2):46‑51. (In Russ.)

МСФ на ЯМ
Close metadata
Recommended articles:
Reco­nstructive plastic surgery in combined treatment of breast cancer: predictive risk factors of complications and reco­nstruction failure. P.A. Herzen Journal of Onco­logy. 2024;(3):13-19
Stra­tegy for early diagnosis of skin mela­noma. Effe­ctiveness of onco­dermatology screenings. P.A. Herzen Journal of Onco­logy. 2024;(3):46-52
Targeted lymphadenectomy with sentinel lymph node biopsy in patients with breast cancer cT1-3N1M0 after neoadjuvant poly­chemotherapy. P.A. Herzen Journal of Onco­logy. 2024;(3):73-78
Breast cancer: types of implantable mate­rials for replacement of postresection defe­cts. P.A. Herzen Journal of Onco­logy. 2024;(3):85-89
Gender differences in mental and beha­vioural diso­rders as an impo­rtant stage of cardiovascular diseases prevention in young people. Russian Journal of Preventive Medi­cine. 2024;(3):66-71
Colo­rectal cancer: inci­dence, risk factors, and screening. Russian Journal of Preventive Medi­cine. 2024;(3):93-97
Comparative immu­nohistochemistry study of different anti­bodies clones for dete­ction of breast cancer markers (estrogen rece­ptor, progesterone rece­ptor, HER2/neu, Ki-67). Russian Journal of Archive of Pathology. 2024;(2):14-20
Complications after one-stage and two-stage breast reco­nstruction depe­nding on the method of reco­nstruction and risk factors. Plastic Surgery and Aesthetic Medi­cine. 2024;(2):16-21
Perforator fasciocutaneous flaps in rese­ctions for breast cancer. Plastic Surgery and Aesthetic Medi­cine. 2024;(2):81-86
The impact of arti­ficial inte­lligence on double reading of mammograms. Russian Journal of Preventive Medi­cine. 2024;(5):32-37

The paper gives a brief review of basic breast cancer (BC) screening techniques of the 20th century. Mammography as a screening method is proven to be effective in reducing BC mortality and its difficulties and disadvantages are indicated. Transition to digital technologies is the main area in the development of a mammology service today. In late 2010, a total of 2460 up-to-date X-ray mammography devices (XMD) were available in the health care facilities of the country, of them there were 185 devices with a stereotactic attachment (including 56 devices with a digital one), 63 digital XMDs, 48 movable mammography rooms, and more than 123 XMDs with CR complexes. By taking into account interval (15-25%) and X-ray negative (4-12%) BCs, the false-negative (4-12%) and false-positive (10-25%) mammogram results, carcinoma in situ diagnostic problems, radiation load, and mammography failure in young/reproductive-aged women, and great government expenditures, it is relevant to practically introduce effective screening programs for BC prevention and to rationally use available health care resources, electrophysiological no-dose technologies. Work is now underway toward the optimization of existing screening programs and the analysis of generalized data on the practical application of no-dose screening technologies.

Keywords:

breast cancer
screening
mammography
no-dose technologies

Authors:

Chissov V.I.

Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena Rosmedtekhnologiĭ, Moskva

Solodky V.A.

Russian Research Center for Radiology of Healthcare Ministry of the Russian Federation, Moscow, Russia

Pak D.D.

FGBU "Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena" Minzdravsotsrazvitiia Rossii

Rozhkova N.I.

FGBU "Rossiĭskiĭ nauchnyĭ tsentr rentgenoradiologii" Minzdrava Rossii, Moskva

Ermoshchenkova M.V.

FGBU "Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena" Minzdravsotsrazvitiia Rossii

Kireeva M.N.

FGBU "Rossiĭskiĭ nauchnyĭ tsentr rentgenoradiologii" Minzdrava Rossii, Moskva

List of references:

  1. Chissov V.I., Starinskii V.V., Petrova G.V., red. Zlokachestvennye novoobrazovaniya v Rossii v 2010 godu (zabolevaemost' i smertnost'). M.; 2012. 260 s.
  2. Korzhenkova G.P. Skrining raka molochnoi zhelezy. V kn.: Materialy mezhdunarodnogo mezhuniversitetskogo seminara po diagnosticheskoi i terapevticheskoi radiologii "Radiologiya v meditsinskoi diagnostike". Minsk; 2003: 82-3.
  3. Korzhenkova G.P. Skrining raka molochnoi zhelezy. 2010. URL: http://mfvt.ru/skrining-raka-molochnoj-zhelezy/.
  4. Semiglazov V.F., Semiglazov V.V. Skrining raka molochnoi zhelezy. Prakticheskaya onkologiya. 2010; 11 (2): 60-5.
  5. MacMahon B., Purde M., Cramer D., Hint E. Association of breast cancer risk with age at first and subsequent births: a study in the population of the Estonian Republic. J. Natl. Cancer Inst. 1982; 69 (5): 1035-8.
  6. Adamyan A.T., Smol'yaninov E.S., Vasil'ev N.V. Tipologicheskii analiz reaktsii sistemy immuniteta u bol'nykh rakom molochnoi zhelezy i zdorovykh. Immunologiya. 1989; 5: 56-9.
  7. Kunitsyna G.A., Mikhin V.V. Organizatsiya aktivnogo poiska predopukholevykh zabolevanii i rannikh form raka molochnoi zhelezy na promyshlennom predpriyatii. Zdravookhranenie Rossiiskoi Federatsii. 1988; 1: 11-4.
  8. Kunitsyna G.A., Takhtamysh A.N. Kompleksnaya diagnostika nachal'nykh stadii raka molochnoi zhelezy. Mammologiya. 1995; 3: 57-69.
  9. Levshin V.F. Skrining raka molochnoi zhelezy. Vestnik RONTs im. N.N. Blokhina. 1999; 4: 60-7.
  10. Levshin V.F., Mikhailov E.A. Samoobsledovanie kak metod skrininga raka molochnoi zhelezy. Voprosy onkologii. 2000; 46 (5): 627-9.
  11. Pak D.D., Rasskazova E.A., Ermoshchenkova M.V. Rak molochnoi zhelezy. M.; 2010. 160 s.
  12. Kuligina E.Sh. Epidemiologicheskie i molekulyarnye aspekty raka molochnoi zhelezy. Prakticheskaya onkologiya. 2010; 11 (4): 203-16.
  13. Singletary S.E. Rating the risk factors for breast cancer. Ann. Surg. 2003; 237: 474-82.
  14. Hakama M. Implementation of screening as a public health policy. J. Med. Screen. 2005; 13: 209-16.
  15. O'Brien J.M. Environmental and heritable factors in the causation of cancer: analyses of cohorts of twins from Sweden, Denmark, and Finland, by P. Lichtenstein, N.V. Holm, P.K. Verkasalo,
  16. Ivanov V.G. Epidemiologicheskie faktory riska, rannyaya diagnostika raka molochnoi zhelezy. Prakticheskaya onkologiya. 2002; 3 (1): 1-5.
  17. Muranova O.Yu. Faktory riska raka molochnoi zhelezy. Sibirskii onkologicheskii zhurnal. 2007; Prilozhenie 2.
  18. Zakharova N.A., Semiglazov V.F., Duffy S.W. Skrining raka molochnoi zhelezy: problemy i resheniya. M.; 2011. 176 s.
  19. Collette H. Further evidence of benefits of a breast cancer screening programme: the DOM project. J. Epidemiol. Commun. Health. 1992; 46: 382-6.
  20. Costanza M., Foster R. Relathion ship between breast self-examination and death from breast cancer by age groups. Cancer Detect. Prev. 1984; 7 (2): 103-8.
  21. Mikhailov E.A. Provedenie programmy RF/VOZ po obucheniyu zhenshchin samoobsledovaniyu molochnykh zhelez v Moskve. V kn.: Aktual'nye problemy profilaktiki neinfektsionnykh zabolevanii. M.; 1995: 107.
  22. Tekkel M.Yu. Sovmestnoe deistvie ioniziruyushchei radiatsii i drugikh faktorov riska na zabolevaemost' rakom molochnoi zhelezy. Voprosy onkologii. 1989; 35 (14): 1379-81.
  23. Stevens V.M., Hatcher J.W., Bruce B.K. How compliant is compliant? Evaluating adherence with breast self-exam positions. J. Behav. Med. 1994; 17 (5): 523-34.
  24. Semiglazov V.F. Rak molochnoi zhelezy: Profilaktika, diagnostika, lechenie. Alma-Ata: Gylym; 1992. 184 s.
  25. Yoo B.N., Choi K.S., Jung K.W., Jun J.K. Awareness and practice of breast self-examination among Korean women: results from
  26. Yadollahie M., Simi A., Habibzadeh F., Ghashghaiee R.T., Karimi S., Behzadi P. et al. Knowledge of and attitudes toward breast self-examination in Iranian women: a multi-center study. Asian Pac. J. Cancer Prev. 2011; 12 (8): 1917-24.
  27. Bland K.I., Copeland E.M., eds. The Breast. Comprehensive management of benign and malignant diseases. Elsevier Health Sciences; 2009. 1712 p.
  28. Putyrskii Yu.L. Metody skrininga raka molochnoi zhelezy. Meditsinskie novosti. 2007; 11: 20-4.
  29. Maheu C., Apostolidis T., Petri-Cal A., Mouret-Fourme E., Gauthier-Villars M., Lasset C. et al. French women's breast self-examination practices with time after undergoing BRCA1/2 genetic testing. Fam. Cancer. 2012; 18.
  30. Ma I., Dueck A., Gray R., Wasif N., Giurescu M., Lorans R. et al. Clinical and self breast examination remain important in the era of modern screening. Ann. Surg. Oncol. 2012; 19 (5): 1484-90.
  31. Panieri E. Breast cancer screening in developing countries. Best Pract. Res. Clin. Obstet. Gynaecol. 2012; 26 (2): 283-90.
  32. Baines C.J. Breast self-examination. Cancer. 1992; 69 (7): 1942-6.
  33. Ciatto S., Rosselli del Turco M., Catarzi S., Cataliotti L., Cardona G., Teglia C. et al. Causes of breast cancer misdiagnosis at physical examination. Neoplasma. 1991; 38 (5): 523-31.
  34. Lengyel L. Breast self examination, its value and difficulties. Orv. Hetil. 1983; 124 (8): 459-60.
  35. Lengyel L., Kozlovzsky B., Halász L., Fábián E., Péter M., Gergely I. et al. Data on screening of breast cancer in Hungary. Organization of breast cancer screening in Debrecen and the results of the past 18 months. Orv. Hetil. 1983; 124 (25): 1497-502.
  36. Jatoi I. Breast cancer screening. Am. J Surg. 1999; 177 (6): 518-24.
  37. Jatoi I. Screening clinical breast examination. Surg. Clin. North Am. 2003; 83 (4): 789-801.
  38. Jatoi I., Anderson W.F. Cancer screening. Curr. Probl. Surg. 2005; 42 (9): 620-82.
  39. Anderson W.F., Jatoi I., Devesa S.S. Distinct breast cancer incidence and prognostic patterns in the NCI's SEER program: suggesting a possible link between etiology and outcome. Breast Cancer Res. Treat. 2005; 90 (2): 127-37.
  40. Bender H.G., Schnürch H.G., Beck L. Breast cancer detection: age-related significance of findings on physical exam and mammography. Gynecol. Oncol. 1988; 31 (1): 166-75.
  41. Kolb T.M., Lichy J., Newhouse J.H. Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. Radiology. 2002; 225 (1): 165-75.
  42. Han M.A., Jun J.K., Choi K.S., Park E.C., Lee H.Y. Satisfaction in the National Cancer Screening Program for Breast Cancer with and without Clinical Breast Examination. Asian Pac. J. Cancer Prev. 2012; 13 (1): 63-7.
  43. Pamilo M., Soiva M., Anttinen I., Roiha M., Suramo I. Ultrasonography of breast lesions detected in mammography screening. Acta Radiol. 1991; 32 (3): 220-5.
  44. Lindenbraten L.D., Burdina L.M., Pinkhosevich E.G. Mammografiya. M.: Vidar; 1997. 123 s.
  45. Komarova L.E. Skrining raka molochnoi zhelezy. Sovremennaya onkologiya. 2006; 4 (2): 83-6.
  46. Shapiro S., Venet W., Strax P. et al. Periodic screening for breast cancer. Baltimore: Johns Hopkins University Press; 1988.
  47. Dodd G.D. Screening for the early detection of breast cancer. Cancer. 1988; 62 (8, Suppl.): 1783-4.
  48. Strax P. Mass screening to reduce mortality from breast cancer. Seminars Surg. Oncol. 1988; 4 (4): 218-20.
  49. Rakowski W., Breen N., Meissner H., Rimer B.K., Vernon S.W., Clark M.A., Freedman A.N. Prevalence and correlates of repeat mammography among women aged 55-79 in the Year 2000 National Health Interview Survey. Prev. Med. 2004; 39 (1): 1-10.
  50. Shootman M., Jeffe D., Reschke A., Aft R. The full potential of breast cancer screening use to reduce mortality has not yet been realized in the United States. Breast Cancer Res. Treat. 2004; 85 (3): 219-22.
  51. Smith R.A., Duffy S.W., Gabe R., Tabar L., Yen A.M., Chen T.H. The randomized trials of breast cancer screening: what have we learned? Radiol Clin North Am. 2004; 42 (5): 793-806.
  52. Hopper J.L., Chenevix-Trench G., Jolley D.J., Dite G.S., Jenkins M.A., Venter D.J. et al. Design and analysis issues in a population-based, case-control-family study of the genetic epidemiology of breast cancer and the Co-operative Family Registry for Breast Cancer Studies (CFRBCS). J. Natl. Cancer Inst. Monogr. 1999; 26: 95-100.
  53. Kelsey J.L., Gammon M.D. The epidemiology of breast cancer. CA Cancer. J. Clin. 1991; 41 (3): 146-65.
  54. Dales L.G., Friedman G.D., Collen M.F. Evaluating periodic multiphasic health checkups: a controlled trial. J. Chronic. Dis. 1979; 32 (5): 385-404.
  55. Tabár L., Smith R.A., Duffy S.W. Update on effects of screening mammography. Lancet. 2002; 360 (9329): 337; author reply 339-40.
  56. Tabar L., Gad A. Screening for breast cancer: the Swedish trial. Radiology. 1981; 138 (1): 219-22.
  57. Tabar L., Fagerberg G., Duffy S.W., Day N.E. The Swedish two county trial of mammographic screening for breast cancer: recent results and calculation of benefit. J. Epidemiol. Community Health. 1989; 43 (2): 107-14.
  58. Duffy S.W., Smith R.A., Gabe R., Tabár L., Yen A.M., Chen T.H. Screening for breast cancer. Surg. Oncol. Clin. North Am. 2005; 14 (4): 671-97.
  59. Semiglazov V.F. Programma skrininga dlya vyyavleniya raka molochnoi zhelezy. V kn.: Demidov V.P., red. Rak molochnoi zhelezy: Sbornik nauchnykh trudov. M.; 1991: 32-7.
  60. Getsshe Peter K., Oslen Ole. Opravdana li mammografiya dlya skrininga raka molochnoi zhelezy? Mezhdunarodnyi meditsinskii zhurnal. 2000; 3: 221-7.
  61. Elmore J.G., Barton M.B., Moceri V.M. Ten-year risk of false positive screening mammograms and clinical breast examinations. N. Engl. J. Med. 1998; 338: 1089-96.
  62. Tabar L., Gad A., Hoimberg L. Reduction in advanced breast cancer: results of the first seven years of mammography screening in Kopparberg, Sweden. Diagn. Imaging Clin. Med. 1984; 54: 158-64.
  63. Frisell J., Glas U., Hellstrom L., Somell A. Randomized mamkographic screening or breast cancer in Stockholm: design, first round results and comparisons. Breast Cancer Res. Treat. 1986; 8: 45-54.
  64. Bjurstam N., Bjomeld L., Duffy S.W. The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization. Cancer. 1997; 80: 2091-9.
  65. Anderson I., Aspegen K., Janzon L. Mammographic screening and mortality from breast cancer: the Malmo mammographic screening trial. Br. Med. J. 1988; 297: 943-8.
  66. Nyström L., Rutquist L.E., Walls S. Breast cancer screening with mammography: overview of Swedish randomized trilas. Lancet. 1993; 341: 973-8.
  67. Tabar L., Chen H.H., Fagerberg G., Duffy S.W., Smith T.C. Recent results from the Swedish Two-County Trial: the effects of age, histologic type, and mode of detection on the efficacy of breast cancer screening. J. Natl. Cancer Inst. Monogr. 1997; 22: 43-7.
  68. Semiglazov V.F. Skrining na rak molochnoi zhelezy: deistvennaya mera spaseniya zhizni. Meditsinskii vestnik. 2008; 35 (462): 7-8.
  69. Fletcher S.W. Breast Cancer Screening Among Women in their Forties: An overview of the issues. In: National Institutes of Health. NIH consensus development conference breast cancer screening for women ages 40-49. January 21-23, 1997: 19-22.
  70. Ernster V. Increases in Ductal Carcinoma in situ in relation to mammography: a dilemma. In: National Institutes of Health. NIH consensus development conference breast cancer screening for women ages 40-49. January 21-23, 1997: 147-51.
  71. Vysotskaya I.V., Letyagin V.P., Abashin S.Yu., Pogodina E.M. Lechenie rannikh form raka molochnoi zhelezy. M.; 2000: 10-2.
  72. Korzhenkova G.P. V kn.: Skrining raka molochnoi zhelezy. Materialy mezhdunarodnogo mezhuniversitetskogo seminara po diagnosticheskoi i terapevticheskoi radiologii "Radiologiya v meditsinskoi diagnostike". Minsk; 2003: 82-3.
  73. Anderson T.J., Waller M., Ellis I.O., Bobrow L., Moss S. Influence of annual mammography from age 40 on breast cancer pathology. Hum. Pathol. 2004; 35 (10): 1252-9.
  74. Briasoulis E., Karavasilis V., Kostadima L., Ignatiadis M., Fountzilas G., Pavlidis N. Metastatic breast carcinoma confined to bone: portrait of a clinical entity. Cancer. 2004; 101 (7): 1524-8.
  75. Trokhanova O.V. Otsenka sostoyaniya molochnykh zhelez v norme i pri patologii metodom elektroimpedansnoi mammografii: Dis. ... kand. med. nauk. Yaroslavl'; 2003. 176 s.
  76. Rozhkova N.I., Fomin D.K., Nazarov A.A., Yakobs O.E., Borisova O.A. Elektroimpedansnaya mammografiya v diagnostike raka molochnoi zhelezy. Meditsinskaya radiologiya i radiatsionnaya bezopasnost'. 2009; 4: 47-51.
  77. Sherstneva T.V. Zabolevaemost' zhenshchin, podvergshikhsya radiatsionnomu vozdeistviyu, i organizatsionnaya model' shchadyashchego obsledovaniya: Dis. ... kand. med. nauk. M.; 2005. 137 c.
  78. Yarmolyuk O.P. Sravnitel'naya otsenka metodik issledovaniya molochnykh zhelez pri razlichnykh variantakh techeniya perimenopauzy: Dis. ... kand. med. nauk. Yaroslavl'; 2009. 165 s.
  79. Raneta O., Ondruš D., Bella V. Utilisation of electrical impedance tomography in breast cancer diagnosis. Klin. Onkol. 2012; 25 (1): 36-41.
  80. Prasad S.N., Houserkova D., Campbell J. Breast imaging using 3D electrical impedence tomography. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc. Czech Repub. 2008; 152 (1): 151-4.
  81. Sdvizhkov A.M., Evtyagin V.V., Borisov V.I., Vasil'eva I.D., Kropacheva T.D., Svichkar' I.P. Mammograficheskii skrining raka molochnoi zhelezy. Problemy organizatsii i rezul'taty osushchestvleniya. Vestnik Moskovskogo onkologicheskogo obshchestva. 2006; 11.
  82. Misra S., Solomon N.L., Moffat F.L. Koniaris L.G. Screening criteria for breast cancer. Adv. Surg. 2010; 44: 87-100.
  83. Hassan A.M., El-Shenawee M. Review of electromagnetic techniques for breast cancer detection. IEEE Rev. Biomed. Eng. 2011; 4: 103-18.

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.